Logo image
Se connecter
Docetaxel-estramustine in localized high-risk prostate cancer: Results of the French Genitourinary Tumor Group GETUG 12 phase III trial
Article de revue   Avec comité de lecture

Docetaxel-estramustine in localized high-risk prostate cancer: Results of the French Genitourinary Tumor Group GETUG 12 phase III trial

Karim Fizazi, Agnes Laplanche, Francois Lesaunier, Remy Delva, Gwenaelle Gravis, Frederic Rolland, Frank Priou, Jean Marc Ferrero, Nadine Houede, Loic Mourey, …
Journal of clinical oncology, Vol.32(15_suppl), pp.5005-5005
20/05/2014

Résumé

Abstract only

Indicateurs

1 Consultations de la notice

Détails

Logo image